Synthesis of 18F-labelled fragmented antibody [18F]Fab

被引：0

作者：

Eskola, Olli ^{[1
]}

Yim, Cheng-Bin ^{[2
]}

Johnson, Tim ^{[3
]}

Bergman, Jorgen ^{[2
]}

Solin, Olof ^{[4
]}

机构：

[1] Univ Turku, Turku PET Ctr, Turku, Finland

[2] Turku PET Ctr, Turku, Finland

[3] UCB Pharma, Slough, Berks, England

[4] Univ Turku, Turku, Finland

来源：

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2019年 / 62卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

P-031

引用

页码：S186 / S187

页数：2

共 4 条

[1] A strain-promoted [3+2] azide-alkyne cycloaddition for covalent modification of blomolecules in living systems [J].

Agard, NJ ;

Prescher, JA ;

Bertozzi, CR .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (46) :15046-15047

[2] Preclinical optimization of antibody-based radiopharmaceuticals for cancer imaging and radionuclide therapyModel, vector, and radionuclide selection [J].

Carter, Lukas M. ;

Poty, Sophie ;

Sharma, Sai Kiran ;

Lewis, Jason S. .

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (09) :611-635

[3]

Goldenberg D M, 1997, J Nucl Med Technol, V25, P18

[4] Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives [J].

Viola-Villegas, Nerissa Therese ;

Sevak, Kuntal K. ;

Carlin, Sean D. ;

Doran, Michael G. ;

Evans, Henry W. ;

Bartlett, Derek W. ;

Wu, Anna M. ;

Lewis, Jason S. .

MOLECULAR PHARMACEUTICS, 2014, 11 (11) :3965-3973

← 1 →